222
Views
45
CrossRef citations to date
0
Altmetric
Review

Brain tumors and epilepsy

, &
Pages 941-955 | Published online: 09 Jan 2014

References

  • Ibrahim K, Appleton R. Seizures as the presenting symptom of brain tumours in children. Seizure13(2), 108–112 (2004).
  • Bromfield EB. Epilepsy in patients with brain tumors and other cancers. Rev. Neurol. Dis.1(Suppl. 1), S27–S33 (2004).
  • van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol.6(5), 421–430 (2007).
  • Lynam LM, Lyons MK, Drazkowski JF et al. Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin. Neurol. Neurosurg.109(7), 634–638 (2007).
  • Klein M, Engelberts NH, van der Ploeg HM et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann. Neurol.54(4), 514–520 (2003).
  • Stieber VW. Low-grade gliomas. Curr. Treat. Options Oncol.2(6), 495–506 (2001).
  • Gunnarsson T, Olafsson E, Sighvatsson V, Hannesson B. Surgical treatment of patients with low-grade astrocytomas and medically intractable seizures. Acta Neurol. Scand.105(4), 289–292 (2002).
  • Riva M, Salmaggi A, Marchioni E et al. Tumour-associated epilepsy: clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group. Neurol. Sci.27(5), 345–351 (2006).
  • Hwang SL, Lieu AS, Kuo TH et al. Preoperative and postoperative seizures in patients with astrocytic tumours: analysis of incidence and influencing factors. J. Clin. Neurosci.8(5), 426–429 (2001).
  • Pace A, Bove L, Innocenti P et al. Epilepsy and gliomas: incidence and treatment in 119 patients. J. Exp. Clin. Cancer Res.17(4), 479–482 (1998).
  • Vecht CJ, Wagner GL, Wilms EB. Treating seizures in patients with brain tumors: drug interactions between antiepileptic and chemotherapeutic agents. Semin. Oncol.30(6 Suppl. 19), 49–52 (2003).
  • Nishida N, Hayase Y, Mikuni N et al. A nonspecific form of dysembryoplastic neuroepithelial tumor presenting with intractable epilepsy. Brain Tumor Pathol.22(1), 35–40 (2005).
  • Duggal N, Taylor R, Zou GY, Hammond RR. Dysembryoplastic neuroepithelial tumours: clinical, proliferative and apoptotic features. J. Clin. Pathol.61(1), 127–131 (2008).
  • Kwon KH, Lee JI, Hong SC, Seo DW, Hong SB. Gamma knife radiosurgery for epilepsy related to dysembryoplastic neuroepithelial tumor. Stereotact. Funct. Neurosurg.84(5–6), 243–247 (2006).
  • Lee MC, Kang JY, Seol MB et al. Clinical features and epileptogenesis of dysembryoplastic neuroepithelial tumor. Childs Nerv. Syst.22(12), 1611–1618 (2006).
  • Aronica E, Gorter JA, Redeker S et al. Distribution, characterization and clinical significance of microglia in glioneuronal tumours from patients with chronic intractable epilepsy. Neuropathol. Appl. Neurobiol.31(3), 280–291 (2005).
  • Van den Bent MJ, Reni M, Gatta G, Vecht C. Oligodendroglioma. Crit. Rev. Oncol. Hematol.66(3), 262–72 (2008).
  • Chang EF, Potts MB, Keles GE et al. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J. Neurosurg.108(2), 227–235 (2008).
  • van Breemen MS, Vecht CJ. Optimal seizure management in brain tumor patients. Curr. Neurol. Neurosci. Rep.5(3), 207–213 (2005).
  • Herman ST. Clinical trials for prevention of epileptogenesis. Epilepsy Res.68(1), 35–38 (2006).
  • Glantz MJ, Cole BF, Forsyth PA et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology54(10), 1886–1893 (2000).
  • Pasquier B, Peoc’H M, Fabre-Bocquentin B et al. Surgical pathology of drug-resistant partial epilepsy. A 10-year-experience with a series of 327 consecutive resections. Epileptic Disord.4(2), 99–119 (2002).
  • Herman ST. Epilepsy after brain insult: targeting epileptogenesis. Neurology59(9 Suppl. 5), S21–S26 (2002).
  • Blumcke I, Pauli E, Clusmann H et al. A new clinico-pathological classification system for mesial temporal sclerosis. Acta Neuropathol.113(3), 235–244 (2007).
  • Wuttke TV, Lerche H. Novel anticonvulsant drugs targeting voltage-dependent ion channels. Expert Opin. Investig. Drugs15(10), 1167–1177 (2006).
  • Tang B, Sander T, Craven KB, Hempelmann A, Escayg A. Mutation analysis of the hyperpolarization-activated cyclic nucleotide-gated channels HCN1 and HCN2 in idiopathic generalized epilepsy. Neurobiol. Dis.29(1), 59–70 (2008).
  • Rusconi R, Scalmani P, Cassulini RR et al. Modulatory proteins can rescue a trafficking defective epileptogenic Nav1.1 Na+ channel mutant. J. Neurosci.27(41), 11037–11046 (2007).
  • Patt S, Steenbeck J, Hochstetter A et al. Source localization and possible causes of interictal epileptic activity in tumor-associated epilepsy. Neurobiol. Dis.7(4), 260–269 (2000).
  • Lee MC, Kim GM, Woo YJ et al. Pathogenic significance of neuronal migration disorders in temporal lobe epilepsy. Hum. Pathol.32(6), 643–648 (2001).
  • Perego C, Vanoni C, Bossi M et al. The GLT-1 and GLAST glutamate transporters are expressed on morphologically distinct astrocytes and regulated by neuronal activity in primary hippocampal cocultures. J. Neurochem.75(3), 1076–1084 (2000).
  • Alonso-Nanclares L, De Felipe J. Vesicular glutamate transporter 1 immunostaining in the normal and epileptic human cerebral cortex. Neuroscience134(1), 59–68 (2005).
  • Aronica E, Gorter JA, Jansen GH, Leenstra S, Yankaya B, Troost D. Expression of connexin 43 and connexin 32 gap-junction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex. Acta Neuropathol.101(5), 449–459 (2001).
  • Richardson MP, Hammers A, Brooks DJ, Duncan JS. Benzodiazepine-GABAA receptor binding is very low in dysembryoplastic neuroepithelial tumor: a PET study. Epilepsia42(10), 1327–1334 (2001).
  • di Michele F, Verdecchia M, Dorofeeva M et al. GABAA receptor active steroids are altered in epilepsy patients with tuberous sclerosis. J. Neurol. Neurosurg. Psychiatry74(5), 667–670 (2003).
  • Stefan H, Lopes da Silva FH, Loscher W et al. Epileptogenesis and rational therapeutic strategies. Acta Neurol. Scand.113(3), 139–155 (2006).
  • Aronica E, Yankaya B, Jansen GH et al. Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy. Neuropathol. Appl. Neurobiol.27(3), 223–237 (2001).
  • Schaller B. Influences of brain tumor-associated pH changes and hypoxia on epileptogenesis. Acta Neurol. Scand.111(2), 75–83 (2005).
  • Gu W, Brodtkorb E, Piepoli T, Finocchiaro G, Steinlein OK. LGI1: a gene involved in epileptogenesis and glioma progression? Neurogenetics6(2), 59–66 (2005).
  • Brodtkorb E, Nakken KO, Steinlein OK. No evidence for a seriously increased malignancy risk in LGI1-caused epilepsy. Epilepsy Res.56(2–3), 205–208 (2003).
  • Piepoli T, Jakupoglu C, Gu W et al. Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1. Neuro Oncol.8(2), 96–108 (2006).
  • Bartolomei F, Bosma I, Klein M et al. Disturbed functional connectivity in brain tumour patients: evaluation by graph analysis of synchronization matrices. Clin. Neurophysiol.117(9), 2039–2049 (2006).
  • Bartolomei F, Bosma I, Klein M et al. How do brain tumors alter functional connectivity? A magnetoencephalography study. Ann. Neurol.59(1), 128–138 (2006).
  • Bartolomei F, Wendling F, Regis J, Gavaret M, Guye M, Chauvel P. Pre-ictal synchronicity in limbic networks of mesial temporal lobe epilepsy. Epilepsy Res.61(1–3), 89–104 (2004).
  • Bartolomei F, Chauvel P, Wendling F. [Spatio-temporal dynamics of neuronal networks in partial epilepsy]. Rev. Neurol. (Paris)161(8–9), 767–780 (2005).
  • Stam CJ, Reijneveld JC. Graph theoretical analysis of complex networks in the brain. Nonlinear Biomed. Phys.1(1), 3 (2007).
  • Bartolomei F, Wendling F, Bellanger JJ, Regis J, Chauvel P. Neural networks involving the medial temporal structures in temporal lobe epilepsy. Clin. Neurophysiol.112(9), 1746–1760 (2001).
  • Stam CJ, Jones BF, Nolte G, Breakspear M, Scheltens P. Small-world networks and functional connectivity in Alzheimer’s disease. Cereb. Cortex17(1), 92–99 (2007).
  • Duffau H. Brain plasticity: from pathophysiological mechanisms to therapeutic applications. J. Clin. Neurosci.13(9), 885–897 (2006).
  • Giese A. Glioma invasion – pattern of dissemination by mechanisms of invasion and surgical intervention, pattern of gene expression and its regulatory control by tumorsuppressor p53 and proto-oncogene ETS-1. Acta Neurochir. Suppl.88, 153–162 (2003).
  • Duffau H, Khalil I, Gatignol P, Denvil D, Capelle L. Surgical removal of corpus callosum infiltrated by low-grade glioma: functional outcome and oncological considerations. J. Neurosurg.100(3), 431–437 (2004).
  • Duffau H. New concepts in surgery of WHO grade II gliomas: functional brain mapping, connectionism and plasticity – a review. J. Neurooncol.79(1), 77–115 (2006).
  • Gil Robles S, Gatignol P, Capelle L, Mitchell MC, Duffau H. The role of dominant striatum in language: a study using intraoperative electrical stimulations. J. Neurol. Neurosurg. Psychiatry76(7), 940–946 (2005).
  • Teixidor P, Gatignol P, Leroy M, Masuet-Aumatell C, Capelle L, Duffau H. Assessment of verbal working memory before and after surgery for low-grade glioma. J. Neurooncol.81(3), 305–313 (2007).
  • Jourdan MS, Schneider J, Lutschg J, Weber P. Fast improvement of verbal memory function after left temporal tumour resection. Acta Paediatr.95(10), 1306–1309 (2006).
  • Correa DD, DeAngelis LM, Shi W, Thaler HT, Lin M, Abrey LE. Cognitive functions in low-grade gliomas: disease and treatment effects. J. Neurooncol.81(2), 175–184 (2007).
  • Tucha O, Smely C, Preier M, Lange KW. Cognitive deficits before treatment among patients with brain tumors. Neurosurgery47(2), 324–333 (2000).
  • Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol.3(3), 159–168 (2004).
  • Amaral LA, az-Guilera A, Moreira AA, Goldberger AL, Lipsitz LA. Emergence of complex dynamics in a simple model of signaling networks. Proc. Natl Acad. Sci. USA101(44), 15551–15555 (2004).
  • Duffau H. The anatomo-functional connectivity of language revisited. New insights provided by electrostimulation and tractography. Neuropsychologia46, 927–934 (2008).
  • Liang H, Bressler SL, Ding M, Truccolo WA, Nakamura R. Synchronized activity in prefrontal cortex during anticipation of visuomotor processing. Neuroreport13(16), 2011–2015 (2002).
  • Lowe MJ, Mock BJ, Sorenson JA. Functional connectivity in single and multislice echoplanar imaging using resting-state fluctuations. Neuroimage7(2), 119–132 (1998).
  • Salvador R, Suckling J, Schwarzbauer C, Bullmore E. Undirected graphs of frequency-dependent functional connectivity in whole brain networks. Philos. Trans. R. Soc. Lond. B. Biol. Sci.360(1457), 937–946 (2005).
  • Stam CJ, van Cappellen van Walsum AM, Micheloyannis S. Variability of EEG synchronization during a working memory task in healthy subjects. Int. J. Psychophysiol.46(1), 53–66 (2002).
  • Schnitzler A, Gross J. Functional connectivity analysis in magnetoencephalography. Int. Rev. Neurobiol.68, 173–195 (2005).
  • Hadjipapas A, Hillebrand A, Holliday IE, Singh KD, Barnes GR. Assessing interactions of linear and nonlinear neuronal sources using MEG beamformers: a proof of concept. Clin. Neurophysiol.116(6), 1300–1313 (2005).
  • Marrelec C, Bellec P, Krainik A et al. Regions, systems, and the brain: hierarchical measures of functional integration in fMRI. Med. Image Anal. (2008) (In press).
  • Sporns O, Chialvo DR, Kaiser M, Hilgetag CC. Organization, development and function of complex brain networks. Trends Cogn. Sci.8(9), 418–425 (2004).
  • Strogatz SH. Exploring complex networks. Nature410(6825), 268–276 (2001).
  • Halgren E, Boujon C, Clarke J, Wang C, Chauvel P. Rapid distributed fronto-parieto-occipital processing stages during working memory in humans. Cereb. Cortex12(7), 710–728 (2002).
  • von Stein A, Sarnthein J. Different frequencies for different scales of cortical integration: from local gamma to long range a/q synchronization. Int. J. Psychophysiol.38(3), 301–313 (2000).
  • Ponten SC, Bartolomei F, Stam CJ. Small-world networks and epilepsy: graph theoretical analysis of intracerebrally recorded mesial temporal lobe seizures. Clin. Neurophysiol.118(4), 918–927 (2007).
  • Harter D, Kozma R. Chaotic neurodynamics for autonomous agents. IEEE Trans. Neural. Netw.16(3), 565–579 (2005).
  • Chavez M, Hwang DU, Amann A, Boccaletti S. Synchronizing weighted complex networks.Chaos16(1), 015106 (2006).
  • Chavez M, Hwang DU, Amann A, Hentschel HG, Boccaletti S. Synchronization is enhanced in weighted complex networks. Phys. Rev. Lett.94(21), 218701 (2005).
  • Zhang F, Endo S, Cleary LJ, Eskin A, Byrne JH. Role of transforming growth factor-b in long-term synaptic facilitation in Aplysia. Science275(5304), 1318–1320 (1997).
  • Jacobs KM, Donoghue JP. Reshaping the cortical motor map by unmasking latent intracortical connections. Science251(4996), 944–947 (1991).
  • Ivanco TL, Greenough WT. Physiological consequences of morphologically detectable synaptic plasticity: potential uses for examining recovery following damage. Neuropharmacology39(5), 765–776 (2000).
  • Gross CG. Neurogenesis in the adult brain: death of a dogma. Nat. Rev. Neurosci.1(1), 67–73 (2000).
  • Nguyen DK, Botez MI. Diaschisis and neurobehavior. Can. J. Neurol. Sci.25(1), 5–12 (1998).
  • Duffau H. Acute functional reorganisation of the human motor cortex during resection of central lesions: a study using intraoperative brain mapping. J. Neurol. Neurosurg. Psychiatry70(4), 506–513 (2001).
  • Bavelier D, Neville HJ. Cross-modal plasticity: where and how? Nat. Rev. Neurosci.3(6), 443–452 (2002).
  • Draganski B, Gaser C, Busch V, Schuierer G, Bogdahn U, May A. Neuroplasticity: changes in grey matter induced by training. Nature427(6972), 311–312 (2004).
  • Kim OJ, Yong AJ, Chung YS et al. Significance of chronic epilepsy in glial tumors and correlation with surgical strategies. J. Clin. Neurosci.11(7), 702–705 (2004).
  • Duffau H, Capelle L, Lopes M, Bitar A, Sichez JP, Van ER. Medically intractable epilepsy from insular low-grade gliomas: improvement after an extended lesionectomy. Acta Neurochir. (Wien.)144(6), 563–572 (2002).
  • Riva M. Brain tumoral epilepsy: a review. Neurol. Sci.26(Suppl. 1), S40–S42 (2005).
  • Bauer R, Dobesberger J, Unterhofer C et al. Outcome of adult patients with temporal lobe tumours and medically refractory focal epilepsy. Acta Neurochir. (Wien.)149(12), 1211–1216 (2007).
  • Engel J Jr, Burchfiel J, Ebersole J et al. Long-term monitoring for epilepsy. Report of an IFCN committee. Electroencephalogr. Clin. Neurophysiol.87(6), 437–458 (1993).
  • Isnard J, Guenot M, Sindou M, Mauguiere F. Clinical manifestations of insular lobe seizures: a stereo-electroencephalographic study. Epilepsia45(9), 1079–1090 (2004).
  • Wieser HG, Blume WT, Fish D et al. ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia42(2), 282–286 (2001).
  • Karceski S, Morrell MJ, Carpenter D. Treatment of epilepsy in adults: expert opinion, 2005. Epilepsy Behav.7(Suppl. 1), S1–64 (2005).
  • Wagner GL, Wilms EB, Vecht C. [Levetiracetam: an anti-epileptic drug with interesting pharmacokinetic properties]. Ned Tijdschr Geneeskd146(26), 1218–1221 (2002).
  • Acharya S, Bussel JB. Hematologic toxicity of sodium valproate. J. Pediatr. Hematol. Oncol.22(1), 62–65 (2000).
  • Marson AG, Williamson PR, Clough H, Hutton JL, Chadwick DW. Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. Epilepsia43(5), 505–513 (2002).
  • Carreno M. Levetiracetam. Drugs Today (Barc.)43(11), 769–794 (2007).
  • Wick W, Menn O, Meisner C et al. Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long? Onkologie28(8–9), 391–396 (2005).
  • Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology69(18), 1751–1760 (2007).
  • Newton HB, Goldlust SA, Pearl D. Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J. Neurooncol.78(1), 99–102 (2006).
  • Perry JR, Sawka C. Add-on gabapentin for refractory seizures in patients with brain tumours. Can. J. Neurol. Sci.23(2), 128–131 (1996).
  • Khan RB, Hunt DL, Thompson SJ. Gabapentin to control seizures in children undergoing cancer treatment. J. Child Neurol.19(2), 97–101 (2004).
  • Sirven JI, Fife TD, Wingerchuk DM, Drazkowski JF. Second-generation antiepileptic drugs’ impact on balance: a meta-analysis. Mayo Clin. Proc.82(1), 40–47 (2007).
  • Maschio M, Dinapoli L, Zarabla A et al. Outcome and tolerability of topiramate in brain tumor associated epilepsy. J. Neurooncol.86(1), 61–70 (2008).
  • Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol.2(8), 473–481 (2003).
  • Vecht CJ, Wagner GL, Wilms EB. Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol.2(7), 404–409 (2003).
  • Sondergaard KM, Nielsen KA, Dahl M, Wolf P. Lamotrigine therapeutic thresholds. Seizure (2008) (Epub ahead of print).
  • Maschio M, Albani F, Baruzzi A et al. Levetiracetam therapy in patients with brain tumour and epilepsy. J. Neurooncol.80(1), 97–100 (2006).
  • Otoul C, Arrigo C, van RK, French JA. Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy. Clin. Neuropharmacol.28(2), 72–78 (2005).
  • Wagner GL, Wilms EB, van Donselaar CA, Vecht C. Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure12(8), 585–586 (2003).
  • Bourg V, Lebrun C, Chichmanian RM, Thomas P, Frenay M. Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity. Ann. Oncol.12(2), 217–219 (2001).
  • Oberndorfer S, Piribauer M, Marosi C, Lahrmann H, Hitzenberger P, Grisold W. P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J. Neurooncol.72(3), 255–260 (2005).
  • Eyal S, Yagen B, Sobol E, Altschuler Y, Shmuel M, Bialer M. The activity of antiepileptic drugs as histone deacetylase inhibitors. Epilepsia45(7), 737–744 (2004).
  • Chavez-Blanco A, Segura-Pacheco B, Perez-Cardenas E et al. Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A Phase I study. Mol. Cancer4(1), 22 (2005).
  • Li XN, Shu Q, Su JM, Perlaky L, Blaney SM, Lau CC. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC. Mol. Cancer Ther.4(12), 1912–1922 (2005).
  • Tang K, Wong LP, Lee EJ, Chong SS, Lee CG. Genomic evidence for recent positive selection at the human MDR1 gene locus. Hum. Mol. Genet.13(8), 783–797 (2004).
  • Ben-Menachem E. Levetiracetam: treatment in epilepsy. Expert Opin. Pharmacother.4(11), 2079–2088 (2003).
  • Siddiqui TS. Febrile convulsions in children: relationship of family history to type of convulsions and age at presentation. J. Ayub. Med. Coll. Abbottabad.14(4), 26–28 (2002).
  • van Rijckevorsel K, Boon PA. The ‘number needed to treat’ with Levetiracetam (LEV): comparison with the other new antiepileptic drugs (AEDs). Seizure10(3), 235–236 (2001).
  • Stupp R, Pica A, Mirimanoff RO, Michielin O. [A practical guide for the management of gliomas]. Bull Cancer94(9), 817–822 (2007).
  • Kaloshi G, ouaich-Amiel A, Diakite F et al. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology68(21), 1831–1836 (2007).
  • Turnheim K. [Drug interactions with antiepileptic agents]. Wien. Klin. Wochenschr.116(4), 112–118 (2004).
  • Murry DJ, Cherrick I, Salama V et al. Influence of phenytoin on the disposition of irinotecan: a case report. J. Pediatr. Hematol. Oncol.24(2), 130–133 (2002).
  • Maschio M, Dinapoli L, Zarabia A, Jandolo B. Issues related to the pharmacological management of patients with brain tumours and epilepsy. Funct. Neurol.21(1), 15–19 (2006).
  • Stefan H, Wang Y, Pauli E, Schmidt B. A new approach in anti-epileptic drug evaluation. Eur. J. Neurol.11(7), 467–473 (2004).
  • Gilbar PJ, Brodribb TR. Phenytoin and fluorouracil interaction. Ann. Pharmacother.35(11), 1367–1370 (2001).
  • Ruegg S. Dexamethasone/phenytoin interactions: neurooncological concerns. Swiss Med. Wkly132(29–30), 425–426 (2002).
  • Wiener P. Neuroactive steroids, relaxation, and seizure control. Int J. Neurosci.113(5), 631–639 (2003).
  • Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS. Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin. Proc.79(12), 1489–1494 (2004).
  • Soffietti R, Leoncini B, Ruda R. New developments in the treatment of malignant gliomas. Expert Rev. Neurother.7(10), 1313–1326 (2007).
  • Claus EB, Black PM. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973–2001. Cancer106(6), 1358–1363 (2006).
  • Duffau H. [Management of low-grade gliomas]. Rev. Prat.56(16), 1771–1777 (2006).
  • Boiardi A, Silvani A, Eoli M et al. Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival? J. Neurooncol.88(1), 105–113 (2008).
  • Devinsky O. Patients with refractory seizures. N. Engl. J. Med.340(20), 1565–1570 (1999).
  • Loscher W, Potschka H. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J. Pharmacol. Exp. Ther.301(1), 7–14 (2002).
  • Anderson GD, Shen DD. Where is the evidence that p-glycoprotein limits brain uptake of antiepileptic drug and contributes to drug resistance in epilepsy? Epilepsia48(12), 2372–2374 (2007).
  • Tan NC, Berkovic SF. Prediction of drug resistance in epilepsy: not as easy as ABC. Lancet Neurol.5(8), 641–642 (2006).
  • Van Vliet EA, van SR, Edelbroek PM, Redeker S et al. Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats. Epilepsia47(4), 672–680 (2006).
  • Hermann DM, Kilic E, Spudich A, Kramer SD, Wunderli-Allenspach H, Bassetti CL. Role of drug efflux carriers in the healthy and diseased brain. Ann. Neurol.60(5), 489–498 (2006).
  • Rogawski MA. New evidence supporting a role for T-type Ca2+ channels in absence epilepsy and in the action of ethosuximide. Epilepsy Curr.2(2), 57 (2002).
  • Calatozzolo C, Gelati M, Ciusani E et al. Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma. J. Neurooncol.74(2), 113–121 (2005).
  • Aronica E, Gorter JA, Van Vliet EA et al. Overexpression of the human major vault protein in gangliogliomas. Epilepsia44(9), 1166–1175 (2003).
  • Baltes S, Fedrowitz M, Tortos CL, Potschka H, Loscher W. Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays. J. Pharmacol. Exp. Ther.320(1), 331–343 (2007).
  • Potschka H, Baltes S, Loscher W. Inhibition of multidrug transporters by verapamil or probenecid does not alter blood-brain barrier penetration of levetiracetam in rats. Epilepsy Res.58(2–3), 85–91 (2004).
  • Goldman B. Multidrug resistance: can new drugs help chemotherapy score against cancer? J. Natl Cancer Inst.95(4), 255–257 (2003).
  • Duffau H, Capelle L. Preferential brain locations of low-grade gliomas. Cancer100(12), 2622–2626 (2004).
  • Labyt E, Houdayer E, Cassim F, Bourriez JL, Derambure P, Devanne H. Motor representation areas in epileptic patients with focal motor seizures: a TMS study. Epilepsy Res.75(2–3), 197–205 (2007).
  • Augustine JR. Circuitry and functional aspects of the insular lobe in primates including humans. Brain Res. Brain Res. Rev.22(3), 229–244 (1996).
  • Zilles K, Schlaug G, Geyer S et al. Anatomy and transmitter receptors of the supplementary motor areas in the human and nonhuman primate brain. Adv. Neurol.70, 29–43 (1996).
  • Rivier F, Clarke S. Cytochrome oxidase, acetylcholinesterase, and NADPH-diaphorase staining in human supratemporal and insular cortex: evidence for multiple auditory areas. Neuroimage6(4), 288–304 (1997).
  • Krainik A, Lehericy S, Duffau H et al. Role of the supplementary motor area in motor deficit following medial frontal lobe surgery. Neurology57(5), 871–878 (2001).
  • Dronkers NF. A new brain region for coordinating speech articulation. Nature384(6605), 159–161 (1996).
  • Hatten ME. New directions in neuronal migration. Science297(5587), 1660–1663 (2002).
  • Rakic P. Molecular and cellular mechanisms of neuronal migration: relevance to cortical epilepsies. Adv. Neurol.84, 1–14 (2000).
  • Barba C, Doglietto F, Policicchio D, Caulo M, Colicchio G. Unusual ipsilateral hyperkinetic automatisms in SMA seizures. Seizure14(5), 354–361 (2005).
  • Isnard J, Guenot M, Ostrowsky K, Sindou M, Mauguiere F. The role of the insular cortex in temporal lobe epilepsy. Ann. Neurol.48(4), 614–623 (2000).
  • Fields RD, Stevens-Graham B. New insights into neuron-glia communication. Science298(5593), 556–562 (2002).
  • Aubert A, Costalat R, Duffau H, Benali H. Modeling of pathophysiological coupling between brain electrical activation, energy metabolism and hemodynamics: insights for the interpretation of intracerebral tumor imaging. Acta Biotheor.50(4), 281–295 (2002).
  • Hennessy MJ, Elwes RD, Binnie CD, Polkey CE. Failed surgery for epilepsy. A study of persistence and recurrence of seizures following temporal resection. Brain123(Pt 12), 2445–2466 (2000).
  • Wolf HK, Campos MG, Zentner J et al. Surgical pathology of temporal lobe epilepsy. Experience with 216 cases.J. Neuropathol. Exp. Neurol.52(5), 499–506 (1993).
  • Plate KH, Wieser HG, Yasargil MG, Wiestler OD. Neuropathological findings in 224 patients with temporal lobe epilepsy. Acta Neuropathol.86(5), 433–438 (1993).
  • Panda S, Radhakrishnan VV, Radhakrishnan K, Rao RM, Sarma SP. Electro-clinical characteristics and postoperative outcome of medically refractory tumoral temporal lobe epilepsy. Neurol. India53(1), 66–71 (2005).
  • Duffau H. Contribution of cortical and subcortical electrostimulation in brain glioma surgery: methodological and functional considerations. Neurophysiol. Clin.37(6), 373–382 (2007).
  • Duffau H. Intraoperative cortico-subcortical stimulations in surgery of low-grade gliomas. Expert Rev. Neurother.5(4), 473–485 (2005).
  • Sanai N, Mirzadeh Z, Berger MS. Functional outcome after language mapping for glioma resection. N. Engl. J. Med.358(1), 18–27 (2008).
  • Ojemann G, Ojemann J, Lettich E, Berger M. Cortical language localization in left, dominant hemisphere. An electrical stimulation mapping investigation in 117 patients. 1989. J. Neurosurg.108(2), 411–421 (2008).
  • Duffau H, Denvil D, Lopes M et al. Intraoperative mapping of the cortical areas involved in multiplication and subtraction: an electrostimulation study in a patient with a left parietal glioma. J. Neurol. Neurosurg. Psychiatry73(6), 733–738 (2002).
  • Duffau H, Capelle L, Denvil D et al. The role of dominant premotor cortex in language: a study using intraoperative functional mapping in awake patients. Neuroimage20(4), 1903–1914 (2003).
  • Duffau H, Denvil D, Capelle L. Long term reshaping of language, sensory, and motor maps after glioma resection: a new parameter to integrate in the surgical strategy. J. Neurol. Neurosurg. Psychiatry72(4), 511–516 (2002).
  • Duffau H, Gatignol P, Mandonnet E, Peruzzi P, Tzourio-Mazoyer N, Capelle L. New insights into the anatomo-functional connectivity of the semantic system: a study using cortico-subcortical electrostimulations. Brain128(Pt 4), 797–810 (2005).
  • Duffau H, Gatignol P, Denvil D, Lopes M, Capelle L. The articulatory loop: study of the subcortical connectivity by electrostimulation. Neuroreport14(15), 2005–2008 (2003).
  • Bartolomeo P, de Schotten MT, Duffau H. Mapping of visuospatial functions during brain surgery: a new tool to prevent unilateral spatial neglect. Neurosurgery61(6), E1340 (2007).
  • Duffau H, Bauchet L, Lehericy S, Capelle L. Functional compensation of the left dominant insula for language. Neuroreport12(10), 2159–2163 (2001).
  • Duffau H. Recovery from complete hemiplegia following resection of a retrocentral metastasis: the prognostic value of intraoperative cortical stimulation. J. Neurosurg.95(6), 1050–1052 (2001).
  • Duffau H, Sichez JP, Lehericy S. Intraoperative unmasking of brain redundant motor sites during resection of a precentral angioma: evidence using direct cortical stimulation. Ann. Neurol.47(1), 132–135 (2000).
  • Cataltepe O, Turanli G, Yalnizoglu D, Topcu M, Akalan N. Surgical management of temporal lobe tumor-related epilepsy in children. J. Neurosurg.102(3 Suppl.), 280–287 (2005).
  • Jorge CL, Nagahashi-Marie SK, Pedreira CC et al. Clinical characteristics and surgical outcome of patients with temporal lobe tumors and epilepsy. Arq. Neuropsiquiatr.58(4), 1002–1008 (2000).
  • Zaatreh MM, Firlik KS, Spencer DD, Spencer SS. Temporal lobe tumoral epilepsy: characteristics and predictors of surgical outcome. Neurology61(5), 636–641 (2003).
  • Fried I, Kim JH, Spencer DD. Limbic and neocortical gliomas associated with intractable seizures: a distinct clinicopathological group. Neurosurgery34(5), 815–823 (1994).
  • Peraud A, Meschede M, Eisner W, Ilmberger J, Reulen HJ. Surgical resection of grade II astrocytomas in the superior frontal gyrus. Neurosurgery50(5), 966–975 (2002).
  • Sugano H, Shimizu H, Sunaga S. Efficacy of intraoperative electrocorticography for assessing seizure outcomes in intractable epilepsy patients with temporal-lobe-mass lesions. Seizure16(2), 120–127 (2007).
  • Moore PM, Baker GA. The neuropsychological and emotional consequences of living with intractable temporal lobe epilepsy: implications for clinical management. Seizure11(4), 224–230 (2002).
  • Duffau H, Velut S, Mitchell MC, Gatignol P, Capelle L. Intra-operative mapping of the subcortical visual pathways using direct electrical stimulations. Acta Neurochir. (Wien.)146(3), 265–269 (2004).
  • Duffau H, Capelle L, Sichez N et al. Intraoperative mapping of the subcortical language pathways using direct stimulations. An anatomo-functional study. Brain125(Pt 1), 199–214 (2002).
  • Mandonnet E, Nouet A, Gatignol P, Capelle L, Duffau H. Does the left inferior longitudinal fasciculus play a role in language? A brain stimulation study. Brain130(Pt 3), 623–629 (2007).
  • Aronica E, Redeker S, Boer K et al. Inhibitory networks in epilepsy-associated gangliogliomas and in the perilesional epileptic cortex. Epilepsy Res.74(1), 33–44 (2007).
  • Mittelbronn M, Schittenhelm J, Lemke D et al. Low grade ganglioglioma rapidly progressing to a WHO grade IV tumor showing malignant transformation in both astroglial and neuronal cell components. Neuropathology27(5), 463–467 (2007).
  • Salanova V, Markand O, Worth R. Temporal lobe epilepsy: analysis of patients with dual pathology. Acta Neurol. Scand.109(2), 126–131 (2004).
  • Roper SN, Levesque MF, Sutherling WW, Engel J Jr. Surgical treatment of partial epilepsy arising from the insular cortex. Report of two cases. J. Neurosurg.79(2), 266–269 (1993).
  • Ebeling U, Kothbauer K. Circumscribed low grade astrocytomas in the dominant opercular and insular region: a pilot study. Acta Neurochir. (Wien.)132(1–3), 66–74 (1995).
  • Yasargil MG, Reeves JD. Tumours of the limbic and paralimbic system. Acta Neurochir. (Wien.)116(2–4), 147–149 (1992).
  • Zentner J, Meyer B, Stangl A, Schramm J. Intrinsic tumors of the insula: a prospective surgical study of 30 patients. J. Neurosurg.85(2), 263–271 (1996).
  • Isnard J, Mauguiere F. [The insula in partial epilepsy]. Rev. Neurol. (Paris)161(1), 17–26 (2005).
  • Ostrowsky K, Isnard J, Ryvlin P, Guenot M, Fischer C, Mauguiere F. Functional mapping of the insular cortex: clinical implication in temporal lobe epilepsy. Epilepsia41(6), 681–686 (2000).
  • Petrides M, Pandya DN. Efferent association pathways from the rostral prefrontal cortex in the macaque monkey. J. Neurosci.27(43), 11573–11586 (2007).
  • Duffau H, Capelle L, Lopes M, Faillot T, Sichez JP, Fohanno D. The insular lobe: physiopathological and surgical considerations. Neurosurgery47(4), 801–810 (2000).
  • Lang FF, Olansen NE, DeMonte F et al. Surgical resection of intrinsic insular tumors: complication avoidance. J. Neurosurg.95(4), 638–650 (2001).
  • Munari C, Musolino A, umas-Duport C et al. Correlation between stereo-EEG, CT-scan and stereotactic biopsy data in epileptic patients with low-grade gliomas. Appl. Neurophysiol.48(1–6), 448–453 (1985).
  • Gil Robles S, Tancu H, El Fertit H et al. Stereo EEG of insular cortex with occipito-insular electrodes in temporal plus or fronto-opercular epilepsy. Presented at: ESSFN 2006 (18th Congress). Montreaux, Switzerland, 4–7 October, 2006.
  • Schiffbauer H, Ferrari P, Rowley HA, Berger MS, Roberts TP. Functional activity within brain tumors: a magnetic source imaging study. Neurosurgery49(6), 1313–1320 (2001).
  • Kozma R, Puljic M, Balister P, Bollobas B, Freeman WJ. Phase transitions in the neuropercolation model of neural populations with mixed local and non-local interactions. Biol. Cybern.92(6), 367–379 (2005).
  • Micheloyannis S, Pachou E, Stam CJ et al. Small-world networks and disturbed functional connectivity in schizophrenia. Schizophr. Res.87(1–3), 60–66 (2006).
  • Reijneveld JC, Ponten SC, Berendse HW, Stam CJ. The application of graph theoretical analysis to complex networks in the brain. Clin. Neurophysiol.118(11), 2317–2331 (2007).
  • Khan RB, Onar A. Seizure recurrence and risk factors after antiepilepsy drug withdrawal in children with brain tumors. Epilepsia47(2), 375–379 (2006).
  • Mathieu D, Kondziolka D, Niranjan A, Flickinger J, Lunsford LD. Gamma knife radiosurgery for refractory epilepsy caused by hypothalamic hamartomas. Stereotact. Funct. Neurosurg.84(2–3), 82–87 (2006).
  • Chalifoux R, Elisevich K. Effect of ionizing radiation on partial seizures attributable to malignant cerebral tumors. Stereotact. Funct. Neurosurg.67(3–4), 169–182 (1996).
  • Warnke PC, Berlis A, Weyerbrock A, Ostertag CB. Significant reduction of seizure incidence and increase of benzodiazepine receptor density after interstitial radiosurgery in low-grade gliomas. Acta Neurochir. Suppl.68, 90–92 (1997).
  • Schrottner O, Unger F, Eder HG, Feichtinger M, Pendl G. Gamma-knife radiosurgery of mesiotemporal tumour epilepsy observations and long-term results. Acta Neurochir. Suppl.84, 49–55 (2002).
  • Hildebrand J. Management of epileptic seizures. Curr. Opin. Oncol.16(4), 314–317 (2004).
  • Brada M, Viviers L, Abson C et al. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann. Oncol.14(12), 1715–1721 (2003).
  • Pace A, Vidiri A, Galie E et al. Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann. Oncol.14(12), 1722–1726 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.